Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2012 Nov 15.

Published in final edited form as: Clin Cancer Res. 2011 Nov 8;17(22):7164–7173. doi: 10.1158/1078-0432.CCR-11-0649

Fig. 1 — Patient 24 had a subcarinal lymph node mass measuring 2.8 cm (panel A) which decreased to 0.8 cm (panel B) after 10 months of vaccine, a > 50% reduction by RECIST, followed by a CR after 18 months (panel C). She remains on study 37 months after enrollment, with a durable CR.

Fig. 1 — Patient 24 had a subcarinal lymph node mass measuring 2.8 cm (panel A) which decreased to 0.8 cm (panel B) after 10 months of vaccine, a > 50% reduction by RECIST, followed by a CR after 18 months (panel C). She remains on study 37 months after enrollment, with a durable CR.